Ivabradine in heart failure-no paradigm SHIFT ... yet

被引：38

作者：

Teerlink, John R. ^{[1
,2
]}

机构：

[1] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA

[2] San Francisco VA Med Ctr, San Francisco, CA 94121 USA

来源：

LANCET | 2010年 / 376卷 / 9744期

关键词：

CARDIAC-INSUFFICIENCY BISOPROLOL; PLACEBO-CONTROLLED TRIAL; RATE REDUCTION; RANDOMIZED-TRIAL; I-F; CARVEDILOL; DISEASE; DYSFUNCTION; METOPROLOL; CIBIS;

D O I：

10.1016/S0140-6736(10)61314-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：847 / 849

页数：3

共 19 条

[11] A RANDOMIZED TRIAL OF BETA-BLOCKADE IN HEART-FAILURE - THE CARDIAC-INSUFFICIENCY BISOPROLOL STUDY (CIBIS) [J].

LECHAT, P ;

JAILLON, P ;

FONTAINE, ML ;

CHANTON, E ;

MESENGE, C ;

GAGEY, S ;

GUILLARDEAU, A ;

DUSSOUS, V .

CIRCULATION, 1994, 90 (04) :1765-1773

[12]

MacMahon S, 1997, LANCET, V349, P375

[13] Direct evidence for calcium conductance of hyperpolarization-activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations [J].

Michels, Guido ;

Brandt, Mathias C. ;

Zagidullin, Naufal ;

Khan, Ismail F. ;

Larbig, Robert ;

van Aaken, Sebastian ;

Wippermann, Jens ;

Hoppe, Uta C. .

CARDIOVASCULAR RESEARCH, 2008, 78 (03) :466-475

[14] Effect of carvedilol on survival in severe chronic heart failure. [J].

Packer, M ;

Coats, AJS ;

Fowler, MB ;

Katus, HA ;

Krum, H ;

Mohacsi, P ;

Rouleau, JL ;

Tendera, M ;

Castaigne, A ;

Roecker, EB ;

Schultz, MK ;

DeMets, DL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (22) :1651-1658

[15] The effect of carvedilol on morbidity and mortality in patients with chronic heart failure [J].

Packer, M ;

Bristow, MR ;

Cohn, JN ;

Colucci, WS ;

Fowler, MB ;

Gilbert, EM ;

Shusterman, NH .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1349-1355

[16] Elevated Heart Rate in Cardiovascular Diseases: A Target for Treatment? [J].

Palatini, Paolo .

PROGRESS IN CARDIOVASCULAR DISEASES, 2009, 52 (01) :46-60

[17] Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial [J].

Poole-Wilson, PA ;

Swedberg, K ;

Cleland, JGF ;

Di Lenarda, A ;

Hanrath, P ;

Komajda, M ;

Lubsen, J ;

Lutiger, E ;

Metra, M ;

Remme, WJ ;

Torp-Pedersen, C ;

Scherhag, A ;

Skene, A .

LANCET, 2003, 362 (9377) :7-13

[18]

SWEDBERG K, 2010, LANCET, DOI DOI 10.1016/501406736(10)61198-1

[19] Fallacies in clinical cardiovascular trials [J].

Swedberg, Karl .

HEART, 2009, 95 (17) :1464-1468

← 1 2 →